Adeno Associated Virus Vector Manufacturing Market Size | Projected CAGR of 12.8%, Reaching USD 3.21 Billion by 2030 | Key Players: Sarepta Therapeutics (North America)

Adeno-Associated Virus Vector Manufacturing Market Poised for $3.21 Billion Boom by 2030
The global Adeno-Associated Virus (AAV) Vector Manufacturing Market is on a significant growth trajectory, driven by advancements in gene therapy research and increasing demand for gene-based treatments. Maximize Market Research forecasts the market to reach a staggering USD 3.21 billion by 2030, reflecting a CAGR of approximately 12.8%.
read more..